newsfilter
← Latest News
Business Wire·

Satellos to Participate in November 2024 Investor Conferences

Satellos Bioscience Inc. ("Satellos" or the "Company") (TSX:MSCL) (OTCQB:MSCLF), a public biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders,